|
|
|
|
|
|
Found 61 studies with search of: | "Carvedilol" |
Hide studies that are not seeking new volunteers.
|
|
1 | Completed | A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure | ||||
Condition: | Congestive Heart Failure | |||||
Interventions: | Drug: carvedilol controlled release; Drug: carvedilol immediate release | |||||
2 | Recruiting | Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease | ||||
Condition: | Pre-Hypertension | |||||
Interventions: | Drug: carvedilol phosphate; Drug: lisinopril; Drug: carvedilol phosphate and lisinopril | |||||
3 | Not yet recruiting | Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril | ||||
Condition: | Hypertension | |||||
Interventions: | Drug: carvedilol; Drug: valsartan | |||||
4 | Recruiting | Losartan Anti-Atherosclerosis Study | ||||
Condition: | Hypertension | |||||
Interventions: | Drug: losartan potassium; Drug: Comparator: carvedilol; Drug: Comparator: carvedilol (+) hydrochlorothiazide; Drug: losartan (+) hydrochlorothiazide | |||||
5 | Completed | Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg | ||||
Condition: | Healthy | |||||
Interventions: | Drug: Carvedilol Tablets 12.5 mg; Drug: Coreg® Tablets 12.5 mg | |||||
6 | Completed | Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg | ||||
Condition: | Healthy | |||||
Interventions: | Drug: Carvedilol Tablets 12.5 mg; Drug: Coreg® Tablets 12.5 mg | |||||
7 | Not yet recruiting | The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease | ||||
Conditions: | Hypertension; Coronary Artery Disease | |||||
Interventions: | Drug: Nebivolol; Drug: Carvedilol | |||||
8 | Recruiting | Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease | ||||
Conditions: | Vascular Disease; Kidney Disease | |||||
Interventions: | Drug: Carvedilol; Drug: Placebo | |||||
9 | Completed | Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery | ||||
Conditions: | Coronary Disease; Atrial Fibrillation | |||||
Intervention: | Drug: Carvedilol versus Metoprolol | |||||
10 | Recruiting | Danish Carvedilol Study in Portal Hypertension | ||||
Conditions: | Cirrhosis; Portal Hypertension | |||||
Intervention: | Drug: carvedilol or propranolol | |||||
11 | Terminated | A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension | ||||
Condition: | Hypertension | |||||
Intervention: | Drug: Carvedilol | |||||
12 | Active, not recruiting | The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial | ||||
Condition: | Hypertension | |||||
Interventions: | Drug: lisinopril; Drug: carvedilol controlled release formulation | |||||
13 | Completed | Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension | ||||
Condition: | Hypertension, Pulmonary | |||||
Intervention: | Drug: spironolactone captopril carvedilol | |||||
14 | Recruiting | Coreg CR, Blood Vessel Stiffness and Blood Vessel Function | ||||
Conditions: | Endothelial Function; Diabetes Mellitus; Hypertension | |||||
Interventions: | Drug: carvedilol; Drug: metoprolol extended release | |||||
15 | Completed | A Study to Compare COREG CR to COREG CR Fixed-Dose Combination in Patients With High Blood Pressure | ||||
Condition: | Hypertension | |||||
Intervention: | Drug: SK&F-105517 (COREG CR FDC) | |||||
16 | Completed | A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL. | ||||
Condition: | Hypertension | |||||
Interventions: | Drug: COREG CR; Drug: Lisinopril | |||||
17 | Active, not recruiting | Study to Evaluate the Safety of Twice Daily Oral Carvedilol | ||||
Condition: | Congestive Heart Failure | |||||
Intervention: | Drug: Carvedilol | |||||
18 | Recruiting | The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy | ||||
Conditions: | Duchenne Muscular Dystrophy; Cardiomyopathies | |||||
Intervention: | Drug: Carvedilol | |||||
19 | Completed | Effects of Carvedilol on Cocaine Use in Humans - 11 | ||||
Condition: | Cocaine-Related Disorders | |||||
Intervention: | Drug: Carvedilol | |||||
20 | Recruiting | Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure | ||||
Condition: | Chronic Heart Failure | |||||
Interventions: | Drug: carvedilol; Drug: bisoprolol; Drug: Nebivolol | |||||
21 | Terminated | A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure | ||||
Conditions: | Heart Failure; Chronic Obstructive Airway Disease | |||||
Interventions: | Drug: Carvedilol; Drug: Metoprolol | |||||
22 | Completed | Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes | ||||
Conditions: | Hypertension; Type 2 Diabetes Mellitus | |||||
Interventions: | Drug: carvedilol; Drug: metoprolol | |||||
23 | Recruiting | Therapy With Verapamil or Carvedilol in Chronic Heart Failure | ||||
Condition: | Dilated Cardiomyopathy | |||||
Interventions: | Drug: Verapamil; Drug: Carvedilol | |||||
24 | Active, not recruiting | Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure | ||||
Condition: | Congestive Heart Failure | |||||
Intervention: | Drug: carvedilol | |||||
25 | Completed | Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension | ||||
Conditions: | Non-Insulin-Dependent Diabetes Mellitus; Hypertension | |||||
Interventions: | Drug: carvedilol; Drug: metoprolol | |||||
26 | Completed | Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension | ||||
Conditions: | Non-Insulin-Dependent Diabetes Mellitus; Hypertension | |||||
Interventions: | Drug: carvedilol; Drug: metoprolol | |||||
27 | Active, not recruiting | Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-Daily or Twice-Daily Coreg | ||||
Condition: | Chronic Heart Failure | |||||
Intervention: | Drug: carvedilol | |||||
28 | Terminated | COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria | ||||
Conditions: | Hypertension; Microalbuminuria | |||||
Interventions: | Drug: metoprolol xl; Drug: carvedilol MR; Drug: lisinopril | |||||
29 | Active, not recruiting | The CLEVER Study - Coreg And Left Ventricular Mass Regression | ||||
Conditions: | Hypertension; Left Ventricular Hypertrophy | |||||
Interventions: | Drug: carvedilol MR; Drug: atenolol; Drug: lisinopril | |||||
30 | Active, not recruiting | COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension | ||||
Conditions: | Hypertension; Dyslipidemia | |||||
Interventions: | Drug: Carvedilol Phosphate modified release formulation; Drug: metoprolol succinate | |||||
31 | Recruiting | Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure | ||||
Condition: | Hypertension | |||||
Interventions: | Drug: Carvedilol CR; Drug: Atenolol | |||||
32 | Completed | Effects of Carvedilol on Health Outcomes in Heart Failure | ||||
Condition: | Heart Failure, Congestive | |||||
Intervention: | Drug: carvedilol plus nurse management | |||||
33 | Recruiting | The Vascular Effects of Carvedilol CR + Lisinopril Versus Lisinopril + Hydrochlorothiazide in Abdominally Obese Hypertensive Patients | ||||
Conditions: | Abdominal Obesity; Hypertension | |||||
Intervention: | Drug: carvedilol cr, lisinopril, hydrochlorothiazide | |||||
34 | Completed | Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components | ||||
Condition: | Hypertension | |||||
Intervention: | Drug: COREG CR | |||||
35 | Recruiting | P-Glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy. | ||||
Condition: | Epilepsy | |||||
Intervention: | Drug: Carvedilol-CR | |||||
36 | Completed | Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives | ||||
Condition: | Hypertension | |||||
Intervention: | Drug: carvedilol CR + lisinopril | |||||
37 | Completed | Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril. | ||||
Condition: | Hypertension | |||||
Intervention: | Drug: COREG CR and lisinopril (FDC) | |||||
38 | Completed | Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril. | ||||
Condition: | Hypertension | |||||
Intervention: | Drug: COREG CR and lisinopril (FDC) | |||||
39 | Active, not recruiting | Research Study To Test Coreg CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure | ||||
Condition: | Stage 1 or 2 Essential Hypertension | |||||
Intervention: | Drug: carvedilol controlled release/lisinopril | |||||
40 | Completed | The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure | ||||
Condition: | Heart Diseases | |||||
Intervention: | Drug: Carvedilol | |||||
41 | Active, not recruiting | Comparison of Blood Pressure Medications on Metabolism | ||||
Condition: | Diabetes | |||||
Interventions: | Drug: carvedilol; Drug: metoprolol | |||||
42 | Not yet recruiting | Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI. | ||||
Conditions: | Diabetes Mellitus, Type 2; Hypertension | |||||
Interventions: | Drug: Carvedilol; Drug: Lisinopril; Drug: Hydrochlorothiazide | |||||
43 | Not yet recruiting | A Phase I/II Clinical Study of SK&F-105517-D in Patients With Chronic Heart Failure | ||||
Condition: | Chronic Heart Failure | |||||
Intervention: | Drug: carvedilol phosphate | |||||
44 | Active, not recruiting | The Development of Tolerance to α1-Adrenoceptor Blockade With Chronic Carvedilol Treatment | ||||
Condition: | Heart Failure | |||||
Intervention: | Drug: phenylephrine | |||||
45 | Recruiting | Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure Monitoring for Cardiovascular Risk Assessment | ||||
Conditions: | Essential Hypertension; Total Mortality; Cardiovascular Disease; Stroke; Chronic Kidney Disease | |||||
Interventions: | Drug: Any antihypertensive medication alone or in combination; Drug: Any antihypertensive medication alone or in combination; Device: Ambulatory blood pressure monitoring | |||||
46 | Active, not recruiting | Evaluation of Heart Failure Treatment Guided by NTproBNP vs Clinical Symptoms and Signs Alone | ||||
Conditions: | Heart Failure; Ventricular Dysfunction, Left | |||||
Interventions: | Drug: Captopril; Drug: Enalapril; Drug: Lisinopril; Drug: Ramipril; Drug: Trandolapril; Drug: Bisoprolol; Drug: Carvedilol; Drug: Metoprolol succinate; Drug: Candesartan; Drug: Valsartan; Drug: Eplerenone; Drug: Spironolactone; Drug: Diuretics; Drug: HF treatment according to Swedish guidelines; Procedure: Blood samples; Procedure: KCCQ Questionnaire | |||||
47 | Recruiting | Cocaine Withdrawal and Pharmacotherapy Response | ||||
Condition: | The Focus of This Study is to Reduce Cocaine Use in Methadone | |||||
Intervention: | Drug: Carvedilol | |||||
48 | Completed | Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) | ||||
Condition: | Heart Failure | |||||
Interventions: | Drug: Beta-blockers including Carvedilol; Drug: ACE inhibitors | |||||
49 | Completed | Beta-2 Polymorphisms and Beta Receptor Selectivity | ||||
Condition: | Heart Failure | |||||
Intervention: | Drug: Terbutaline plus Metoprolol or carvedilol | |||||
50 | Terminated | Nebivolol Versus Carvedilol in Patients With Heart Failure | ||||
Conditions: | Chronic Heart Failure; Hypertension | |||||
Intervention: | ||||||
Studies Shown (1-50) | Next (51-61) |